Differential Diagnoses for Extensive Facial Depigmentation with Hyperpigmented Islands
While vitiligo is the most likely diagnosis given 70% facial depigmentation with scattered hyperpigmented islands, you must systematically exclude other depigmenting disorders before finalizing treatment decisions.
Key Differential Diagnoses to Consider
Based on the British Journal of Dermatology vitiligo guidelines 1, the following conditions should be actively ruled out:
Primary Considerations
Pityriasis alba - Look for:
- Fine scaling (absent in your case, which argues against this)
- Ill-defined borders
- Typically smaller, less extensive patches
- More common in children
- Dermoscopy shows faint pigment network and widespread scaling 2
Pityriasis versicolor (hypopigmented variant) - Examine for:
- Fine scale on scraping
- Involvement of trunk/shoulders (not just face)
- KOH preparation showing "spaghetti and meatballs"
- Note: Dermoscopy has only 52.6% sensitivity for this condition 2
Post-inflammatory hypopigmentation - Requires:
- Clear history of preceding inflammatory dermatosis (eczema, psoriasis, trauma)
- Pattern matching previous inflammation distribution
- Usually incomplete depigmentation
Less Common But Important Exclusions
Nevus depigmentosus - Distinguished by:
- Present since birth or early childhood
- Stable, non-progressive
- Dermoscopy: 100% sensitivity with specific features 2
- Does not show the progressive spread typical of vitiligo
Idiopathic guttate hypomelanosis - Characterized by:
- Small (2-5mm), discrete, porcelain-white macules
- Primarily on sun-exposed extremities, not typically 70% of face
- Dermoscopy: 100% diagnostic sensitivity 2
Progressive and extensive hypomelanosis - Consider in:
- Patients with darker skin phototypes
- Relapsing hypochromic macules after summer sun exposure
- Spreads over large areas 3
- May overlap with extensive pityriasis alba
Serious Conditions Requiring Exclusion
Hypopigmented mycosis fungoides - Red flags include:
- Poikilodermatous changes (atrophy, telangiectasia, pigment variation)
- Patches with slight scale or atrophy
- Dermoscopy sensitivity only 81.2% 2
- Requires biopsy if suspected - look for atypical lymphocytes, epidermotropism
Lichen sclerosus (if genital involvement) - Features:
- Porcelain-white atrophic patches
- Primarily anogenital distribution
- Surface changes with atrophy
Chemical/drug-induced depigmentation - Obtain history of:
- Topical hydroquinone or phenolic compound exposure
- Systemic medications (antimalarials, chemotherapy)
- Occupational chemical exposures
Diagnostic Approach Algorithm
Wood's lamp examination - Vitiligo shows bright white fluorescence with sharp borders; other conditions show less distinct enhancement 1
Dermoscopic evaluation - Vitiligo-specific features include 2:
- Starburst pattern (unique to vitiligo)
- Micro-koebnerization (unique to vitiligo)
- Trichrome pattern (unique to vitiligo)
- Perifollicular pigmentation
- Comet-tail appearance
- Dermoscopy has 94.7% sensitivity for vitiligo diagnosis
Check thyroid function - 34% of vitiligo patients have autoimmune thyroid disease 1
Skin biopsy if atypical features present:
- Scaling, atrophy, or surface changes
- Asymmetric or dermatomal distribution
- Lack of classic dermoscopic vitiligo features
- Poikilodermatous changes
Critical Pitfalls to Avoid
- Do not assume vitiligo without Wood's lamp and dermoscopic confirmation - The scattered hyperpigmented islands ("trichrome pattern") actually support vitiligo but must be documented
- Do not miss mycosis fungoides - Any atrophy, scale, or poikiloderma mandates biopsy
- Do not overlook medication history - Chemical leukoderma can mimic vitiligo exactly
- In darker skin types (Fitzpatrick IV-VI), consider progressive extensive hypomelanosis, which may require different management 3
The 70% facial involvement with scattered pigmented islands strongly suggests extensive generalized vitiligo with trichrome pattern, but systematic exclusion of these differentials through history, Wood's lamp, dermoscopy, and selective biopsy is mandatory before committing to long-term vitiligo management or considering depigmentation therapy 1.